E. McFarland

发表

Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study.

R. Gelman, S. Spector, S. Douglas, 2003, The Journal of allergy and clinical immunology.

Safety and Tolerability of Antiretrovirals during Pregnancy

E. Barr, M. Levin, A. Weinberg, 2011, Infectious diseases in obstetrics and gynecology.

Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics Approach

J. Mascola, R. Koup, B. Graham, 2020, Clinical pharmacology and therapeutics.

Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine.

W. Borkowsky, L. Mofenson, S. Spector, 2001, The Journal of infectious diseases.

Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women.

W. Borkowsky, L. Mofenson, D. Francis, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Optimization and Limitations of Use of Cryopreserved Peripheral Blood Mononuclear Cells for Functional and Phenotypic T-Cell Characterization

P. Defechereux, A. Sevin, A. Weinberg, 2009, Clinical and Vaccine Immunology.

Phenotypic T Cell Characterization: Optimization and Limitations

A. Sevin, A. Weinberg, E. McFarland, 2009 .

Components of metabolic syndrome associated with lower neurocognitive performance in youth with perinatally acquired HIV and youth who are HIV-exposed uninfected

S. Nichols, D. Jacobson, M. Geffner, 2021, Journal of NeuroVirology.

Clinical features and treatment of infection due to mycobacterium fortuitum/chelonae complex.

D. Kuritzkes, E. McFarland, 1993, Current clinical topics in infectious diseases.

The interaction between equipoise and logistics in clinical trials: A case study

V. Carey, H. Spiegel, E. Abrams, 2017, Clinical trials.

Prevalence and Persistence of Varicella Antibodies in Previously Immunized Children and Youth With Perinatal HIV-1 Infection.

S. Spector, S. Nichols, T. Yao, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Update on Pediatric Human Immunodeficiency Virus Infection: Paradigms in Treatment and Prevention.

E. McFarland, Christiana Smith, 2016, Advances in pediatrics.

Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir

E. Barr, M. Levin, Jeri E. Forster, 2016, Infectious diseases in obstetrics and gynecology.

A Comparison of Metabolic Outcomes Between Obese HIV-Exposed Uninfected Youth From the PHACS SMARTT Study and HIV-Unexposed Youth From the NHANES Study in the United States.

W. Borkowsky, D. Jacobson, M. Geffner, 2019, Journal of acquired immune deficiency syndromes.

Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants.

J. Mascola, G. Theron, B. Graham, 2021, The Journal of infectious diseases.

Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants.

J. Mascola, J. Safrit, L. Mofenson, 2020, The Journal of infectious diseases.

Associations of FGF21 and GDF15 with mitochondrial dysfunction in children living with perinatally-acquired HIV: A cross-sectional evaluation of pediatric AIDS clinical trials group 219/219C

M. Gerschenson, D. Jacobson, M. Geffner, 2021, PloS one.

Health Outcomes of International HIV-infected Adoptees in the US

E. Barr, Elizabeth R. Wolf, M. Abzug, 2016, The Pediatric infectious disease journal.

HIV Monoclonal Antibodies: A New Opportunity to Further Reduce Mother-to-Child HIV Transmission

P. Kaleebu, J. Safrit, L. Mofenson, 2014, PLoS medicine.

Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge.

M. Pallansch, M. Oberste, W. A. Nix, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children

R. Karron, S. Spector, E. Barr, 2018, The Journal of infectious diseases.

Correlation of HIV-Specific Immunity, Viral Control, and Diversification following Planned Multiple Exposures to Autologous HIV in a Pediatric Population

W. Borkowsky, R. Yogev, E. McFarland, 2011, Clinical and Vaccine Immunology.

Antiretroviral Drug Resistance Among Children and Youth in the United States With Perinatal HIV.

S. Spector, R. Kagan, S. Nichols, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Retention of HIV-Infected Children in the First 12 Months of Anti-Retroviral Therapy and Predictors of Attrition in Resource Limited Settings: A Systematic Review

E. McFarland, L. Abuogi, Christiana Smith, 2016, PloS one.

Risk Factors for Severe COVID-19 in Children.

S. Dominguez, E. McFarland, Kasey Pickard, 2021, The Pediatric infectious disease journal.

Ontogeny of CD4+ T Lymphocytes With Phenotypic Susceptibility to HIV-1 During Exclusive and Nonexclusive Breastfeeding in HIV-1–Exposed Ugandan Infants

M. Fowler, M. Eller, E. Janoff, 2016, The Journal of infectious diseases.

Cytotoxic T lymphocyte lines specific for human immunodeficiency virus type 1 Gag and reverse transcriptase derived from a vertically infected child.

R. Schooley, D. Kuritzkes, T. Curiel, 1993, Journal of Infectious Diseases.

Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines. AIDS Clinical Trial Group 230 Collaborators.

W. Borkowsky, L. Mofenson, S. Spector, 2000, The Journal of infectious diseases.

Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials Group.

W. Borkowsky, S. Spector, R. Yogev, 2000, The Journal of infectious diseases.

Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women.

J. Lambert, S. Gurunathan, G. Tomaras, 2005, The Journal of infectious diseases.

Serious Adverse Events Are Uncommon with Combination Neonatal Antiretroviral Prophylaxis: A Retrospective Case Review

E. Barr, M. Levin, Jeri E. Forster, 2015, PloS one.

Resistance to antiretrovirals in HIV-infected pregnant women.

E. Barr, M. Levin, A. Weinberg, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Textbook of Pediatric HIV Care: The immunology of pediatric HIV disease

E. McFarland, 2005 .

Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatment

Paige L. Williams, W. Borkowsky, L. Dimeglio, 2013, AIDS.

Growth at 2 Years of Age in HIV-exposed Uninfected Children in the United States by Trimester of Maternal Antiretroviral Initiation.

Paige L. Williams, W. Borkowsky, L. Dimeglio, 2016, The Pediatric Infectious Disease Journal.

Kinetics and Determining Factors of the Virologic Response to Antiretrovirals during Pregnancy

E. Barr, M. Levin, C. Peloquin, 2010, Infectious diseases in obstetrics and gynecology.

HIV-1 vaccine induced immune responses in newborns of HIV-1 infected mothers

J. Lambert, S. Gurunathan, G. Tomaras, 2006, AIDS.

HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same Vaccine

W. Borkowsky, M. McElrath, Y. Fong, 2017, Journal of Virology.

Human Immunodeficiency Virus Type 1 DNA Decay Dynamics With Early, Long-term Virologic Control of Perinatal Infection

S. Spector, E. Barr, S. Nichols, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trial

V. Carey, G. Siberry, H. Spiegel, 2017, PloS one.

Planned multiple exposures to autologous virus in HIV type 1-infected pediatric populations increases HIV-specific immunity and reduces HIV viremia.

W. Borkowsky, R. Yogev, E. Capparelli, 2008, AIDS research and human retroviruses.

Youth living with perinatally-acquired HIV have lower physical activity levels as they age compared to HIV-exposed uninfected youth.

Paige L. Williams, D. Jacobson, P. Williams, 2021, Journal of acquired immune deficiency syndromes.

Salivary metabolite levels in perinatally HIV-infected youth with periodontal disease

O. King, A. Moscicki, S. Spector, 2020, Metabolomics.

Remaining Challenges in Pediatric HIV-1 Infection

E. McFarland, Christiana Smith, 2016, Current Pediatrics Reports.

Birth Weight and Preterm Delivery Outcomes of Perinatally vs Nonperinatally Human Immunodeficiency Virus-Infected Pregnant Women in the United States: Results From the PHACS SMARTT Study and IMPAACT P1025 Protocol

M. McNichols, S. Bewley, W. Borkowsky, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cost‐effectiveness of broadly neutralizing antibody prophylaxis for HIV‐exposed infants in sub‐Saharan African settings

M. Weinstein, L. Myer, K. Freedberg, 2023, Journal of the International AIDS Society.

Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses.

Jerome H. Kim, H. Liao, B. Haynes, 2014, The Journal of infectious diseases.

Short communication: The relationship between mitochondrial dysfunction and insulin resistance in HIV-infected children receiving antiretroviral therapy.

M. Gerschenson, D. Jacobson, T. Miller, 2013, AIDS research and human retroviruses.

In vitro effects of IL-12 on HIV-1-specific CTL lines from HIV-1-infected children.

R. Schooley, D. Kuritzkes, E. McFarland, 1998, Journal of immunology.

Diffuse Nodular Lung Infiltrates in a Well Appearing Three-Year-Old Boy With Recurrent Sinopulmonary Infections and Parotitis.

S. Dominguez, E. McFarland, K. Messacar, 2015, Journal of the Pediatric Infectious Diseases Society.

Adverse Pregnancy Outcomes Among Women Who Conceive on Antiretroviral Therapy

S. Spector, L. Aurpibul, J. Currier, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Biomarkers of oral inflammation in perinatally HIV-infected and perinatally HIV exposed, uninfected youth.

Man Wai Ng, A. Moscicki, C. Shiboski, 2019, Journal of clinical periodontology.

Phase I/II trial of intravenous recombinant interleukin-2 in HIV-infected children

M. Levin, S. Douglas, J. Pitt, 2003, AIDS.

Lines from HIV-1-Infected Children In Vitro Effects of IL-12 on HIV-1-Specific CTL

R. Schooley, D. Kuritzkes, E. McFarland, 2017 .

Evaluating ELISPOT summary measures with criteria for obtaining reliable estimates.

A. Baron, E. McFarland, S. MaWhinney, 2005, Journal of immunological methods.

Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children.

R. Karron, S. Spector, P. Collins, 2020, American journal of respiratory and critical care medicine.

HIV Continuum of Care for Youth in the United States

J. Fortenberry, A. Westfall, Jiahong Xu, 2017, Journal of acquired immune deficiency syndromes.

Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children

R. Karron, S. Spector, E. Barr, 2018, The Journal of infectious diseases.

Prevalence of periodontal diseases in a multicenter cohort of perinatally HIV‐infected and HIV‐exposed and uninfected youth

Victor Badner, Ram Yogev, Vivian Olivera, 2017, Journal of clinical periodontology.

Live-attenuated respiratory syncytial virus vaccine with M2-2 deletion and with SH non-coding region is highly immunogenic in children.

R. Karron, E. Barr, P. Collins, 2020, The Journal of infectious diseases.

Clonal CD8+ T cell expansions in peripheral blood from human immunodeficiency virus type 1-infected children.

D. Kuritzkes, E. McFarland, S. MaWhinney, 2002, The Journal of infectious diseases.

Body fat distribution in perinatally HIV-infected and HIV-exposed but uninfected children in the era of highly active antiretroviral therapy: outcomes from the Pediatric HIV/AIDS Cohort Study.

W. Borkowsky, L. Dimeglio, R. Fielding, 2011, The American journal of clinical nutrition.

Body fat distribution in perinatally HIV-infected and HIV-exposed but uninfected children in the era of highly active antiretroviral therapy : outcomes from the Pediatric HIV / AIDS Cohort Study 1 – 4

W. Borkowsky, L. Dimeglio, R. Fielding, 2011 .

Live respiratory syncytial virus attenuated by M2-2 deletion and stabilized temperature sensitivity mutation 1030s is a promising vaccine candidate in children.

R. Karron, S. Spector, E. Barr, 2019, The Journal of infectious diseases.

Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccines RSV/ΔNS2/Δ1313/I1314L and RSV/276 in RSV Seronegative Children.

R. Karron, E. Barr, P. Collins, 2022, The Journal of infectious diseases.

Development and application of a multiplex assay for the simultaneous measurement of antibody responses elicited by common childhood vaccines.

W. Borkowsky, G. Fouda, S. Permar, 2018, Vaccine.

High frequency of Gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection.

D. Kuritzkes, B. Conway, D. Luckey, 1994, The Journal of infectious diseases.

Human immunodeficiency virus infection

E. McFarland, 2011 .

Frequent development of broadly neutralizing antibodies in early life in a large cohort of HIV-infected children

D. Montefiori, Y. Fong, M. A. Moody, 2021, bioRxiv.

Structured treatment interruptions (STIs) in HIV-1 infected pediatric populations increases interferon gamma production and reduces viremia.

W. Borkowsky, R. Yogev, L. Frenkel, 2008, Vaccine.

Vaccines for prevention of mother-to-child transmission of HIV

E. McFarland, C. Cunningham, 2008, Current opinion in HIV and AIDS.

Development and Implementation of an Interdisciplinary Model for the Management of Breastfeeding in Women With HIV in the United States: Experience From the Children's Hospital Colorado Immunodeficiency Program

E. Barr, Rebecca Lynn Johnson, A. Weinberg, 2023, Journal of acquired immune deficiency syndromes.

Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study

S. Spector, E. Barr, S. Nichols, 2018, HIV medicine.

Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV‐infected children

W. Borkowsky, E. Barr, S. Nichols, 2012, HIV medicine.

Live-Attenuated Respiratory Syncytial Virus Vaccine With Deletion of RNA Synthesis Regulatory Protein M2-2 and Cold Passage Mutations Is Overattenuated

R. Karron, E. Barr, Bhagvanji Thumar, 2019, Open Forum Infectious Diseases.

Immunizations for the immunocompromised child.

E. McFarland, E. Mcfarland, 1999, Pediatric annals.

Frequent development of broadly neutralizing antibodies in early life in a large cohort of children living with HIV.

D. Montefiori, Y. Fong, C. Labranche, 2021, The Journal of infectious diseases.

Safety and Tolerability of Antiretrovirals during Pregnancy

E. Barr, M. Levin, A. Weinberg, 2011, Infectious diseases in obstetrics and gynecology.

Textbook of Pediatric HIV Care: The immunology of pediatric HIV disease

E. McFarland, 2005 .

Pharmacokinetics, Tolerability, and Safety of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Week 24 Results From IMPAACT 2014

H. Teppler, L. Aurpibul, E. Cooper, 2022, Journal of acquired immune deficiency syndromes.